Executive Management

Tobin “Toby” Schilke joined Crinetics as Chief Financial Officer in February 2025. Toby is a seasoned biopharma executive with more than 25 years of global pharmaceutical experience. In previous roles, his leadership was instrumental in transforming several biotech companies from R&D-focused entities into fully integrated commercial organizations.  

Prior to Crinetics, Toby served as Chief Financial Officer at Revance Therapeutics, where he oversaw finance, investor relations, IT, and technical operations for a public company with 650 employees, supporting the transformation to a commercial company with two product launches and over $700 million in cumulative revenue. Previously, Toby served as Chief Financial Officer at Achaogen, where he built out the financial planning and analysis, accounting, procurement, information technology, and facilities management functions. Earlier in his career, he spent more than a decade in increasing roles of responsibility at Roche and Genentech in corporate development, commercial finance, marketing, and global operations.  

Toby holds a bachelor’s degree in chemical engineering from Lafayette College, a master’s degree in chemical engineering from the University of California, Berkeley, and a master’s degree in business administration from Cornell University.